BACKGROUND: The management of gliomas is based on precise histologic diagnosis. The tumor tissue can be obtained during open surgery or via stereotactic biopsy. Intraoperative tissue imaging could substantially improve biopsy precision and, ultimately, the extent of resection. OBJECTIVE: To show the feasibility of intraoperative in vivo probe-based confocal laser endomicroscopy (pCLE) in surgery and biopsy of gliomas. METHODS: In our prospective observational study, 9 adult patients were enrolled between September 2014 and January 2015. Two contrast agents were used: 5-aminolevulinic acid (3 cases) or intravenous fluorescein (6 cases). Intraoperative imaging was performed with the Cellvizio system (Mauna Kea Technologies, Paris). A 0.85-mm probe was used for stereotactic procedures, with the biopsy needle modified to have a distal opening. During open brain surgery, a 2.36-mm probe was used. Each series corresponds to a separate histologic fragment. RESULTS: The diagnoses of the lesions were glioblastoma (4 cases), low-grade glioma (2), grade III oligoastrocytoma (2), and lymphoma (1). Autofluorescence of neurons in cortex was observed. Cellvizio images enabled differentiation of healthy "normal" tissue from pathological tissue in open surgery and stereotactic biopsy using fluorescein. 5-Aminolevulinic acid confocal patterns were difficult to establish. No intraoperative complications related to pCLE or to use of either contrast agent were observed. CONCLUSION: We report the initial feasibility and safety of intraoperative pCLE during primary brain tumor resection and stereotactic biopsy procedures. Pending further investigation, pCLE of brain tissue could be utilized for intraoperative surgical guidance, improvement in brain biopsy yield, and optimization of glioma resection via analysis of tumor margins. ABBREVIATIONS: 5-ALA, 5-aminolevulinic acidpCLE, probe-based confocal laser endomicroscopyPpIX, protoporphyrin IX.
BACKGROUND: The management of gliomas is based on precise histologic diagnosis. The tumor tissue can be obtained during open surgery or via stereotactic biopsy. Intraoperative tissue imaging could substantially improve biopsy precision and, ultimately, the extent of resection. OBJECTIVE: To show the feasibility of intraoperative in vivo probe-based confocal laser endomicroscopy (pCLE) in surgery and biopsy of gliomas. METHODS: In our prospective observational study, 9 adult patients were enrolled between September 2014 and January 2015. Two contrast agents were used: 5-aminolevulinic acid (3 cases) or intravenous fluorescein (6 cases). Intraoperative imaging was performed with the Cellvizio system (Mauna Kea Technologies, Paris). A 0.85-mm probe was used for stereotactic procedures, with the biopsy needle modified to have a distal opening. During open brain surgery, a 2.36-mm probe was used. Each series corresponds to a separate histologic fragment. RESULTS: The diagnoses of the lesions were glioblastoma (4 cases), low-grade glioma (2), grade III oligoastrocytoma (2), and lymphoma (1). Autofluorescence of neurons in cortex was observed. Cellvizio images enabled differentiation of healthy "normal" tissue from pathological tissue in open surgery and stereotactic biopsy using fluorescein. 5-Aminolevulinic acid confocal patterns were difficult to establish. No intraoperative complications related to pCLE or to use of either contrast agent were observed. CONCLUSION: We report the initial feasibility and safety of intraoperative pCLE during primary brain tumor resection and stereotactic biopsy procedures. Pending further investigation, pCLE of brain tissue could be utilized for intraoperative surgical guidance, improvement in brain biopsy yield, and optimization of glioma resection via analysis of tumor margins. ABBREVIATIONS: 5-ALA, 5-aminolevulinic acidpCLE, probe-based confocal laser endomicroscopyPpIX, protoporphyrin IX.
Authors: Suman B Mondal; Christine M O'Brien; Kevin Bishop; Ryan C Fields; Julie A Margenthaler; Samuel Achilefu Journal: J Nucl Med Date: 2020-04-17 Impact factor: 10.057
Authors: Evgenii Belykh; Arpan A Patel; Eric J Miller; Baran Bozkurt; Kaan Yağmurlu; Eric C Woolf; Adrienne C Scheck; Jennifer M Eschbacher; Peter Nakaji; Mark C Preul Journal: Cancer Manag Res Date: 2018-08-30 Impact factor: 3.989
Authors: Serik K Akshulakov; Talgat T Kerimbayev; Michael Y Biryuchkov; Yermek A Urunbayev; Dara S Farhadi; Vadim A Byvaltsev Journal: Front Oncol Date: 2019-10-02 Impact factor: 6.244
Authors: Manuel J Marques; Michael R Hughes; Khushi Vyas; Andrew Thrapp; Haojie Zhang; Adrian Bradu; Grigory Gelikonov; Petros Giataganas; Christopher J Payne; Guang-Zhong Yang; Adrian Podoleanu Journal: J Biomed Opt Date: 2019-06 Impact factor: 3.170
Authors: Francesco Acerbi; Bianca Pollo; Camilla De Laurentis; Francesco Restelli; Jacopo Falco; Ignazio G Vetrano; Morgan Broggi; Marco Schiariti; Irene Tramacere; Paolo Ferroli; Francesco DiMeco Journal: Front Oncol Date: 2020-12-23 Impact factor: 6.244
Authors: Francesco Restelli; Bianca Pollo; Ignazio Gaspare Vetrano; Samuele Cabras; Morgan Broggi; Marco Schiariti; Jacopo Falco; Camilla de Laurentis; Gabriella Raccuia; Paolo Ferroli; Francesco Acerbi Journal: J Clin Med Date: 2021-05-10 Impact factor: 4.241